Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis

Journal of Medicinal Food

Volumn 17, Issue 9, 2014, Pages 939-948

  Nam, Sun Young ^a   Oh, Hyun A ^a   Choi, Youngjin ^b   Park, Kun Young ^c   Kim, Hyung Min ^a   Jeong, Hyun Ja ^a,b  

^a Kyung Hee University   (South Korea)

^b Hoseo University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

allergic rhinitis; bamboo salt; cyclooxygenase 2; IL 32; inducible nitric oxide synthase; thymic stromal lymphopoietin

Indexed keywords

BAMBOO SALT; CYCLOOXYGENASE 2; CYTOKINE RECEPTOR ANTAGONIST; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 32; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; SODIUM CHLORIDE; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; BIOLOGICAL PRODUCT; CYTOKINE; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MESSENGER RNA; MINERAL; PTGS2 PROTEIN, HUMAN;

ALLERGIC RHINITIS; ARTICLE; BAMBOO; CELL DIFFERENTIATION; CELL MIGRATION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; INFLAMMATION; METABOLISM; RHINITIS, ALLERGIC; SASA;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; CASPASE 1; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MINERALS; MONOCYTES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RHINITIS, ALLERGIC; RNA, MESSENGER; SASA; SIGNAL TRANSDUCTION; SODIUM CHLORIDE;

EID: 84906980316     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.2996     Document Type: Article

References (44)

1. Bachert C, Jorissen M, Bertrand B, Khaltaev N, Bousquet J: Allergic rhinitis and its impact on asthma update (ARIA) 2008. The Belgian perspective. B-ENT 2008;4:253-257.
2. Mandhane SN, Shah JH, Thennati R: Allergic rhinitis: an update on disease, present treatments and future prospects. Int Im-munopharmacol 2011;11:1646-1662.
3. Bousquet J, Khaltaev N, Cruz AA, et al.: Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008;63:8-160.
4. Pawankar R, Mori S, Ozu C, Kimura S: Overview on the patho-mechanisms of allergic rhinitis. Asia Pac Allergy 2011;1:157-167.
5. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFahpha. Immunity 2005;22: 131-142.
6. Li W, Yang F, Liu Y, et al.: Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 2009;39:1019-1024.
7. Li W, Liu Y, Mukhtar MM, et al.: Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 2008;3:e1985.
8. Shoda H, Fujio K, Yamaguchi Y, et al.: Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006; 8:R166
9. Joosten LA, Netea MG, Kim SH, et al.: IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006;28:3298-3303.
10. Shioya M, Nishida A, Yagi Y, et al.: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007;149:480-486.
11. Vakkila J, Lotze MT: Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004;4:641-648.
12. Calabrese F, Baraldo S, Bazzan E, et al.: IL-32, a novel proin-flammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:894-901.
13. Netea MG, Lewis EC, Azam T, et al.: Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA 2008;105:3515-3520.
14. Jeong HJ, Shin SY, Oh JA, et al.: IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol 2011;224:553-563.
15. Leonard WJ: TSLP: finally in the limelight. Nat Immunol 2002; 3:605-607.
16. Moon PD, Kim HM: Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-kB pathway in mast cells. Cyto-kine 2011;54:239-243.
17. Ziegler SF, Artis D: Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010;11:289-293.
18. Readon C, Lechmann M, Brüstle A, et al.: Thymic stromal lymphopoietin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. Immunity 2011;35:223-235.
19. Watanabe N, Hanabuchi S, Soumelis V, et al.: Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+T cell homeostatic expansion. Nat Immunol 2004;5:426-434.
20. Soumelis V, Reche PA, Kanzler H, et al.: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-680.
21. Bogiatzi SI, Fernandez I, Bchet JC, et al.: Cutting edge: proin-flammatory and Th2 cytokines synergize to induce thymic stro-mal lymphopoietin production by human skin keratinocytes. J Immunol 2007;178:3373-3377.
22. Ying S, O'Connor B, Ratoff J, et al.: Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 2008;181:2790-2798.
23. Mou Z, Xia J, Tan Y, et al.: Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol 2009;129: 297-301.
24. Zhao X, Kim SY, Park KY: Bamboo salt has in vitro anticancer activity in HCT-116 cells and exerts anti-metastatic effects in vivo. J Med Food 2013;16:9-19.
25. Shin HY, Na JH, Moon PD, et al.: Inhibition of mast cell-dependent immediate-type hypersensitivity reactions by purple bamboo salt. J Ethnopharmacol 2004;91:153-157.
26. Sharma NC, Galustians JH, Qaqish JG: An evaluation of a commercial chewing gum in combination with normal tooth-brushing for reducing dental plaque and gingivitis. Compend Contin Educ Dent 2001;22:13-17.
27. Kim KY, Nam SY, Shin TY, et al.: Bamboo salt reduces allergic responses by modulating the caspase-1 activation in an OVA-induced allergic rhinitis mouse model. Food Chem Toxicol 2012;50:3480-3488.
28. Kim SH, Kang SY, Jung KK, et al.: Characterization and anti-gastric ulcer activity of bamboo salt. J Food Hyg Saf 1998;13: 252-257.
29. Jeong HJ, Nam SY, Oh HA, et al.: Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res Ther 2012;14:R259.
30. Stutz A, Golenbock DT, Latz E: Inflammasomes: too big to miss. J Clin Invest 2009;119:3502-3511.
31. Neteal MG, Lewis EC, Azam T, et al.: Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA 2008;105:3515-3520.
32. Galli SJ, Tsai M, Piliponsky AM: The development of allergic inflammation. Nature 2008;454:445-454.
33. Fokkens WJ: Antigen-presenting cells in nasal allergy. Allergy 1999;54:1130-1141.
34. Benson M, Adner M, Cardell LO: Cytokines and cytokine receptors in allergic rhinitis: how do they relate to the Th2 hypothesis in allergy? Clin Exp Allergy 2001;31: 361-367.
35. Rosenwasser LJ: Treatment of allergic rhinitis. Am J Med 2002;113:17S-24S.
36. Borish L, Mascali JJ, Rosenwasser LJ: IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 1991;146:63-67.
37. Broide DH, Lotz M, Cuomo AJ, et al.: Cytokincs in symptomatic airwaays. J Allergy Clin Immunol 1992;89:958-967.
38. Gosset P, Tsicopoulos A, Wallaert B, et al.: Increased secretion of tumor necrosis factor a and interleukin-6 by alveolar macro-phages consecutive to the development of the late asmatic reaction. J Allergy Clin Immunol 1991;88:561-571.
39. Katsumata U, Miwa M, Icinose M, et al.: Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1990;141:1158-1161.
40. Radomski MW, Palmer RM, Moncada S: Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol Sci 1991;12:87-88.
41. Bunyavanich S, Melen E, Wilk JB, et al.: Thymic stromal lym-phopoietin (TSLP) is associated with allergic rhinitis in children with asthma. Clin Mol Allergy 2011;9:1.
42. Netea MG, Azam T, Ferwerda G, et al.: IL-32 synergizes with ucleotide oligomerization domain (NOD) 1 and NOD2 ligands or IL-1beta and IL-6 production through a caspase 1-dependent echanism. Proc Natl Acad Sci USA 2005;102:16309-16314.
43. Bournazou I, Mackenzie KJ, Duffin R, Rossi AG, Gregory CD: Inhibition of eosinophil migration by lactoferrin. Immunol Cell Biol 2010;88:220-223.
44. Tai PC, Spry CJ: The effects of recombinant granulocyte-mac-rophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils. Clin Exp Immunol 1990;80:426-434.